XERS filings
Corporate insider profile
John Johnson Filing Activity
Latest reported as Corporate insider of Xeris Biopharma Holdings, Inc. (XERS).
- Purchase filings
- 0
- Reported companies
- 2
- Net open-market value
- -$569,389.75
- Latest transaction
- Jun 4, 2026
Affiliated corporations
Reported company relationships
Transaction history